Cited by 242Bacterial Infections and VaccinesImmune responses and vaccinationsPneumonia and Respiratory Infections

The DOI matches its Crossref record; the references it cites are not checked yet.

Reduced Response to Multiple Vaccines Sharing Common Protein Epitopes That Are Administered Simultaneously to Infants

Open access
Dagan, Ron, Eskola, Juhani, Leclerc, Claude, Leroy, Odile·1998·Infection and Immunity

Abstract

The plethora of newly discovered vaccines implies that, in the future, many vaccines will have to be administered simultaneously to infants. We examined the potential interference with the immune response of several coadministered vaccines containing the same protein component, namely, tetanus toxoid (TT). Infants simultaneously receiving a tetravalent pneumococcal vaccine conjugated to TT (PncT) and a diphtheria-tetanus-pertussis–poliovirus–Haemophilus influenzae type b-tetanus conjugate vaccine showed significantly lower anti-H. influenzae type b polysaccharide (polyribosylribitol phosphate [PRP]) antibody concentrations than those receiving either a tetravalent pneumococcal vaccine conjugated to diphtheria toxoid or placebo. A dose range study showed that anti-PRP antibody concentrations were inversely related to the TT content of the PncT vaccines administered in infancy. Postimmunization antitetanus antibody concentrations were also affected adversely as the TT content of the coadministered vaccines was increased. This phenomenon, which we believe derives from interference by a common protein carrier, should be taken into account when the introduction of an immunization program including multiple conjugate vaccines is considered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/iai.66.5.2093-2098.1998

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 27 · Cited by 242

Research works printed but not linked: 28

  1. Ahman H. H. Käyhty H. Lehtonen O. Leroy J. Froeschle and J. Eskola. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr. Infect. Dis. J. in press.
  2. Ahman H. Käyhty H. Leroy O. Froeschle J. Eskola J. Immunogenicity of tetravalent pneumococcal (Pnc) conjugate vaccines (PncD PncT) in Finnish infants abstr. G69 Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995 170 American Society for Microbiology Washington D.C
  3. 10.1128/iai.62.1.9-14.1994 · DOI
  4. 10.1128/iai.59.3.1057-1064.1991 · DOI
  5. 10.1128/iai.61.2.432-438.1993 · DOI
  6. 10.1111/j.1749-6632.1995.tb44475.x · DOI
  7. 10.1111/j.1749-6632.1995.tb44458.x · DOI
  8. 10.1097/00006454-199711000-00011 · DOI
  9. 10.1097/00006454-199711000-00010 · DOI
  10. 10.2307/2529425 · DOI
  11. 10.1080/01621459.1955.10501294 · DOI
  12. Fattom A. Cho Y. H. Fuller S. Naso R. Overload of homologous carrier protein at the site of injection might cause a reduced immunogenicity of capsular polysaccharide conjugate vaccines abstr. G93 Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1996 160 American Society for Microbiology Washington D.C
  13. Granoff D. M. M. H. Rathore S. J. Holmes and P. D. Granoff. 1993. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Vaccine 11 (Suppl. 1) : S46–S51. · DOI
  14. 10.1203/00006450-199704001-00729 · DOI
  15. 10.1038/285664a0 · DOI
  16. 10.1084/jem.155.6.1730 · DOI
  17. 10.1111/j.1749-6632.1995.tb44436.x · DOI
  18. 10.1002/eji.1830260625 · DOI
  19. Kurikka S. R.-M. Olander and H. Käyhty. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy. Vaccine in press.
  20. Leclerc C. Schutze M.-P. Deriaud E. Przewlocki G. The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression. J. Immunol. 145 1990 1343 1349 · DOI
  21. 10.1002/eji.1830240509 · DOI
  22. 10.1128/iai.59.10.3504-3510.1991 · DOI · Paper page
  23. 10.1093/infdis/161.5.821 · DOI
  24. 10.1203/00006450-197303000-00001 · DOI
  25. Schutze M.-P. Leclerc C. Jolivet M. Audibert F. Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 135 1985 2319 2322 · DOI
  26. Schutze M.-P. Deriaud E. Przewlocki G. Leclerc C. Carrier-induced epitopic suppression is initiated through clonal dominance. J. Immunol. 142 1989 2635 2640 · DOI
  27. 10.1126/science.8073278 · DOI
  28. 10.1016/S0022-3476(88)80369-X · DOI

Metadata

Authors
Dagan, R., Eskola, J., Leclerc, C., & Leroy, O.
Affiliations
  • Ben-Gurion University of the Negev (IL)
  • <!--label omitted: 3-->National Public Health Institute, Helsinki, Finland3; and
  • Institut Pasteur (FR)
  • <!--label omitted: 5-->Pasteur Mérieux Connaught, Marnes la Coquette,5 France
Venue
Infection and Immunity
Published
1998-05
Volume
66
Issue
5
Pages
2093-2098
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W2169803204
Cited by
242
References
27
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 3 · 2021: 7 · 2020: 2 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 7 · 2015: 4 · 2014: 5 · 2013: 9 · 2012: 5
FWCI
11.90
Type
journal article
Language
en
Open access
Locations
  • Infection and Immunity (publishedVersion)
  • PubMed Central (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
Funders
Kela
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Keywords
vaccine interference, simultaneous vaccination, infants, tetanus toxoid, conjugate vaccines, Haemophilus influenzae type b conjugate vaccine, anti-PrP antibodies, vaccine immunogenicity
MeSH terms
Antibodies, Bacterial, Epitopes, Diphtheria Toxoid, Female, Humans, Infant, Male, Pertussis Vaccine, Poliovirus Vaccine, Inactivated, Polysaccharides, Tetanus Toxoid, Diphtheria-Tetanus-Pertussis Vaccine, Vaccines, Combined, Haemophilus Vaccines, Vaccines, Conjugate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review